Nevertheless, several studies have highlighted that TP53‐mutated LUAD is characterized with higher PD‐L1 expression by malignant cells, boosted T‐cell infiltration and tumor immunogenicity, leading to an increased response to ICIs.7, 32, 33, 34. Here, TP53 is linked to neoplasm.